Navigation Links
Vion Reports 2008 Second Quarter and Six-Month Results
Date:8/4/2008

based on the current operating plan.

Alan Kessman, Chief Executive Officer, commented, "We continue to make progress on a New Drug Application for Cloretazine(R) (VNP40101M) based on our two Phase II trials in elderly patients with acute myelogenous leukemia (AML). We intend to file this NDA in the first half of 2009."

In the quarter the Company exercised its right to appeal a delisting determination to a Nasdaq Listings Qualification Panel and presented a plan for compliance with listing requirements. The Company was notified that the plan was accepted and that it had until August 15, 2008 to implement the plan. The Company has contacted Nasdaq to indicate that it is unlikely that its plan will be implemented by August 15, 2008. Therefore, the Company expects that in the near future it will no longer be listed on the Nasdaq Capital Market and that its common stock will be quoted on the OTC Bulletin Board.

On February 20, 2008, the Company implemented a one-for-ten reverse split of all outstanding shares of its common stock and a corresponding decrease in the number of shares of authorized common stock. Share and per share amounts contained herein are provided on a post-split basis.

Second Quarter Conference Call

The Company announced that it would hold a conference call on Thursday, August 7, 2008 to discuss its 2008 second quarter financial results. The call will begin at 8:30 a.m. Eastern Time.

To participate in the conference call, please dial (800) 591-6930 in the U.S. ((617) 614-4908 for international callers) at least 15 minutes before the start of the call. When prompted for a pass code, please enter 25790591.

An audio webcast of the call will be accessible at http://www.vionpharm.com. Those who wish to listen to the conference call on the Web should visit the Investor Relations section of the Company's website at least 15 minutes prior to the event broadcas
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Masimo Reports Second Quarter 2008 Financial Results
2. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
3. ACS Motion Control Ltd. Reports Second Quarter Results
4. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
5. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
6. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
7. HCA Reports Second Quarter 2008 Results
8. Encision Reports First Fiscal Quarter Results
9. Osteotech Reports 2008 Second Quarter Diluted Earnings Per Share of $.10 on Revenues of $27.6 Million
10. Orchid Cellmark Reports Second Quarter 2008 Financial Results
11. Nutraceutical Reports Q3 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... " Bubbly Walrus ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... games to play on smartphones are the ones that get ... with a video game that just absorbs attention, why not ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 Looking ... that will directly impact your career? The Master ... for dynamic leaders in multinational companies and for ... In a changing global landscape, differences in culture, ... relationships. The EMIB program develops the global competence ...
(Date:5/3/2015)... May 03, 2015 It is not too late ... Aneurysm Walk in Memory of Lissa Anne Been in Arnold, ... this great family-friendly event to honor her loving memory. It has ... , Just having turned 37, Lissa suffered a brain ... on August 24, 2012. This event is designed to serve as ...
(Date:5/2/2015)... Ticket Down has secured additional inventories of authentic ... today, Saturday, May 2nd at the MGM Grand Garden Arena ... to secure tickets for both the actual fight and various ... wanted for more than five years was finally been agreed ... inside the ring to fight Manny “Pac-Man” Pacquiao in what ...
(Date:5/2/2015)... ProText Kinetic 2 is a set of typography creation ... ProText Kinetic 2 features 40 animation presets that ... . Easily create interactive text videos without having to ... 2. , Using ProText Kinetic is as easy as drag ... in the FCPX timeline. Playback the default animation and ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2
... investments in nanoscale science and engineering will create revolutions ... treatment, and space travel. The hope is that many ... nanotechnology enabled products. While new technologies often do ... other social problems or create entirely new ones. The ...
... Reporter , THURSDAY, Nov. 18 (HealthDay News) -- Patients in ... because of cost than residents of other developed countries, a ... industrialized countries, the United States also has the highest out-of-pocket ... "The 2010 survey findings point to glaring gaps in ...
... into mice with metastatic melanoma has resulted in permanent ... cancer, according to an article to be published in ... Clinical Investigation . The online version is now available. ... modified lentivirus to introduce a potent anti-melanoma T cell ...
... nice extra, not a strategic imperative. But the data demonstrate ... L. Berry of Texas A&M University, Ann M. Mirabito of ... Texas MD Anderson Cancer Center. Their research shows that ... is impressive sometimes as high as six to one. ...
... WASHINGTON, Nov. 18, 2010 The latest episode in ... Global Challenges/Chemistry Solutions ," focuses on development and successful ... kills up to 98 percent of disease-causing bacteria in ... technology could aid many of the almost one billion ...
... Ill. -- Taking time off from certain osteoporosis drugs may ... at Loyola University Health System. Researchers found that bone density ... drug holiday from bisphosphonates, a popular class of osteoporosis drugs ... decay in the jaw bone. "These drugs are potentially ...
Cached Medicine News:Health News:Nanotechnology and equity issues explored in new book 2Health News:On Health Policies, U.S. Lags Other Nations: Survey 2Health News:On Health Policies, U.S. Lags Other Nations: Survey 3Health News:On Health Policies, U.S. Lags Other Nations: Survey 4Health News:Gene therapy for metastatic melanoma in mice produces complete remission 2Health News:Wellness programs provide high returns, research reveals 2Health News:Taking a break from osteoporosis drugs can protect bones 2
(Date:5/1/2015)... 1, 2015   Heska Corporation (NASDAQ: HSKA ... provider of advanced veterinary diagnostic and other specialty veterinary ... Chair, will present at the 16th Annual B. Riley & ... 2015. The conference will be held May 12-14, 2015 at ... Heska management will be available during the day on May ...
(Date:5/1/2015)... ANGELES, May 1, 2015  CytRx Corporation (CYTR), ... oncology, today reported financial results for the three ... overview of recent accomplishments and upcoming milestones for ... several milestones in the early months of 2015, ... clinical trial of aldoxorubicin in patients with soft ...
(Date:5/1/2015)... Calif. , May 1, 2015  Legendary actor ... Inc. in a new PBAFacts campaign designed to educate ... to learn more about Pseudobulbar Affect (PBA) and to ... idea that an actor has the ability to cry ... the lack of control experienced by people living with ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Sept. 30 Reportlinker.com announces that a new ... Global Optoelectronics Industry ... analyzes the worldwide markets for Optoelectronics in Millions ... Equipment & Systems, and Optical Components. Major segments ...
... Inc., a developer of a novel platform technology employing ... other peripheral vascular conditions, announced today that veteran medical ... executive officer and a member of the board of ... 25 years of leadership and entrepreneurial experience in health ...
Cached Medicine Technology:Reportlinker Adds Global Optoelectronics Industry 2Reportlinker Adds Global Optoelectronics Industry 3Reportlinker Adds Global Optoelectronics Industry 4Reportlinker Adds Global Optoelectronics Industry 5Reportlinker Adds Global Optoelectronics Industry 6Reportlinker Adds Global Optoelectronics Industry 7Reportlinker Adds Global Optoelectronics Industry 8Reportlinker Adds Global Optoelectronics Industry 9Reportlinker Adds Global Optoelectronics Industry 10Reportlinker Adds Global Optoelectronics Industry 11Reportlinker Adds Global Optoelectronics Industry 12Reportlinker Adds Global Optoelectronics Industry 13Reportlinker Adds Global Optoelectronics Industry 14Reportlinker Adds Global Optoelectronics Industry 15Reportlinker Adds Global Optoelectronics Industry 16Reportlinker Adds Global Optoelectronics Industry 17Reportlinker Adds Global Optoelectronics Industry 18Reportlinker Adds Global Optoelectronics Industry 19Reportlinker Adds Global Optoelectronics Industry 20Reportlinker Adds Global Optoelectronics Industry 21Reportlinker Adds Global Optoelectronics Industry 22Reportlinker Adds Global Optoelectronics Industry 23Reportlinker Adds Global Optoelectronics Industry 24Reportlinker Adds Global Optoelectronics Industry 25Minnow Medical Names Raymond W. Cohen as Chief Executive Officer 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
... Tips are available as both regular and ... by gamma-rays for more efficient sterilization and ... specifying the date of irradiation. Sterilized Diamond ... to autoclave. SterilPack Diamond Tips are wrapped ...
This long 10 L tip features a MicroPoint design for the original Finnpipette 0.5-10 L and the new Finnpipette 0.5-10 L universal fit pipettors....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
Medicine Products: